BE2016C035I2 - - Google Patents

Download PDF

Info

Publication number
BE2016C035I2
BE2016C035I2 BE2016C035C BE2016C035C BE2016C035I2 BE 2016C035 I2 BE2016C035 I2 BE 2016C035I2 BE 2016C035 C BE2016C035 C BE 2016C035C BE 2016C035 C BE2016C035 C BE 2016C035C BE 2016C035 I2 BE2016C035 I2 BE 2016C035I2
Authority
BE
Belgium
Application number
BE2016C035C
Other languages
French (fr)
Original Assignee
Birken Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE2016C035(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Birken Ag filed Critical Birken Ag
Publication of BE2016C035I2 publication Critical patent/BE2016C035I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/37—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings
    • C07C35/42—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings derived from the phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
  • Measuring Volume Flow (AREA)
BE2016C035C 2004-06-22 2016-07-05 BE2016C035I2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004030044A DE102004030044A1 (en) 2004-06-22 2004-06-22 Triterpene-containing oleogel, triterpene-containing oleogel and process for the preparation of a triterpenhaltigen oleogel

Publications (1)

Publication Number Publication Date
BE2016C035I2 true BE2016C035I2 (en) 2024-10-08

Family

ID=34971468

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2016C035C BE2016C035I2 (en) 2004-06-22 2016-07-05

Country Status (31)

Country Link
US (2) US8536380B2 (en)
EP (1) EP1758555B2 (en)
JP (1) JP4468987B2 (en)
KR (1) KR101162991B1 (en)
CN (1) CN1972668B (en)
AT (1) ATE423546T1 (en)
AU (1) AU2005253732C1 (en)
BE (1) BE2016C035I2 (en)
BR (1) BRPI0512288B8 (en)
CA (1) CA2571606C (en)
CY (2) CY1109066T1 (en)
DE (2) DE102004030044A1 (en)
DK (1) DK1758555T4 (en)
ES (1) ES2323082T5 (en)
FR (1) FR16C1003I2 (en)
HU (1) HUS1600032I1 (en)
IL (1) IL180057A (en)
LT (1) LTC1758555I2 (en)
LU (1) LU93142I2 (en)
MX (1) MXPA06015233A (en)
NL (1) NL300823I2 (en)
NO (2) NO336747B1 (en)
NZ (1) NZ552280A (en)
PL (1) PL1758555T5 (en)
PT (1) PT1758555E (en)
RS (1) RS50832B2 (en)
RU (1) RU2430717C2 (en)
SI (1) SI1758555T2 (en)
UA (1) UA88308C2 (en)
WO (1) WO2005123037A1 (en)
ZA (1) ZA200610304B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2332525A1 (en) 2009-11-23 2011-06-15 Novaliq GmbH Pharmaceutical composition comprising propofol
DE102009047092A1 (en) 2009-11-24 2011-05-26 Birken Gmbh Use of a triterpenhaltigen oleogel for wound healing
PL2335675T3 (en) 2009-12-10 2015-08-31 Neubourg Skin Care Gmbh & Co Kg Emulsifier-free, polymer stabilised foam formulas
EP2363108B1 (en) 2010-03-02 2017-08-30 Neubourg Skin Care GmbH & Co. KG Foam formulation containing at least one triterpenoid
EP2723357A4 (en) 2011-06-21 2015-04-01 Bvw Holding Ag Medical device comprising boswellic acid
CA3022218C (en) * 2016-05-12 2023-05-09 Rudjer Boskovic Institute Low molecular weight organic gelators of vegetable oil
US20190183797A1 (en) * 2016-07-18 2019-06-20 Rolf Daniels Betulin-containing water-in-oil foams and compositions thereof
EP3574349B1 (en) * 2017-03-10 2025-08-13 Kraton Polymers U.S. LLC Fusible oil gel compositions and methods of making and using same
KR102692754B1 (en) 2017-08-31 2024-08-08 (주)아모레퍼시픽 Cosmetic composition comprising Centella asiatica extract or Triterpene isolated therefrom with high content, and the method for preparing the same
WO2019089755A1 (en) 2017-10-31 2019-05-09 Western Oncolytics Ltd. Platform oncolytic vector for systemic delivery
BR112020009867A2 (en) 2018-01-04 2020-11-03 Amryt Research Limited creaminess-forming composition
AU2019365255B2 (en) 2018-10-26 2025-06-12 Viramal Limited Mucoadhesive gel composition
EP3659583B1 (en) 2018-11-30 2023-06-07 Viramal Limited A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent
CN109512780A (en) * 2019-01-09 2019-03-26 河南省医药科学研究院 A kind of gel ointment and its preparation method and application
GR1010072B (en) * 2019-05-15 2021-09-15 Αριστοτελειο Πανεπιστημιο Θεσσαλονικης - Ειδικος Λογαριασμος Κονδυλιων Ερευνας Edible veterinary intramammary teat sealant formulations and method for their preparation
JP2023552289A (en) 2020-11-19 2023-12-15 カリヴィル イムノセラピューティクス, インコーポレイテッド Oncolytic immunotherapy by tumor microenvironment remodeling
EP4329786A4 (en) 2021-04-30 2024-12-11 KaliVir Immunotherapeutics, Inc. ONCOLYTIC VIRUSES FOR MODIFIED MHC EXPRESSION
DE102024116319B3 (en) 2024-06-11 2025-10-30 Fuchs SE Lubricating grease compositions containing pentacyclic triterpenes as co-thickeners, their use and methods for their production

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83173A1 (en) 1981-02-27 1981-06-05 Oreal NOVEL COSMETIC COMPOSITIONS FOR THE TREATMENT OF HAIR AND SKIN CONTAINING POWDER RESULTING FROM THE SPRAYING OF AT LEAST ONE PLANT AND A COHESION AGENT
JP3363161B2 (en) 1991-06-27 2003-01-08 ポーラ化成工業株式会社 Non-aqueous gel cosmetic
US5750578A (en) 1997-02-11 1998-05-12 Regents Of The University Of Minnesota Use of betulin and analogs thereof to treat herpesvirus infection
US6403816B1 (en) * 1997-09-30 2002-06-11 Dabur Research Foundation Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
FR2779438B1 (en) * 1998-06-03 2004-12-24 Jean Marc Aiache STABLE GEL, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
GB9908593D0 (en) 1999-04-16 1999-06-09 Quest Int Dental compositions containing boswellia extracts
DK1200106T3 (en) 1999-07-09 2003-10-27 Bsp Pharma As Composition containing Butyrospermum parkii extracts and their use as a drug or dietary supplement
ATE262283T1 (en) 2000-02-10 2004-04-15 Loders Croklaan Bv FAT BLENDS WITH CRYSTAL MODIFIERS
PT1267900E (en) * 2000-03-28 2004-08-31 Birken Gmbh EMULSION CONTAINING A PLANT EXTRACT CONTAINING A TRITERPENE PROCESS FOR THE PREPARATION OF THIS EMULATION AND FOR OBTAINING THE PLANT EXTRACT
DE10056902A1 (en) * 2000-11-16 2002-05-23 Birken Gmbh Recovery of pure terpenes from plants, for use as pharmaceutical or cosmetic active agents, by extracting with solvent at elevated pressure and temperature then cooling and depressurizing to induce crystallization
US6689767B2 (en) 2000-09-29 2004-02-10 Regents Of The University Of Minnesota Triterpenes having antibacterial activity
JP2004509972A (en) 2000-09-29 2004-04-02 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Triterpenes with fungicidal activity against yeast
JP2002138014A (en) 2000-10-31 2002-05-14 Noevir Co Ltd Fine emulsion composition
DE10143964A1 (en) 2001-09-07 2003-03-27 Basf Ag Low-emulsifier or emulsifier-free systems of the oil-in-water type containing stabilizers and an amino-substituted hydroxybenzophenone
DE10156297A1 (en) * 2001-11-19 2003-05-28 Henkel Kgaa Skin protectant, especially hand cream, which remains in place for long periods comprising paraffin oils, petrolatum, carnauba wax and optionally silicon oils and/or additional waxes
JP2003335627A (en) 2002-03-14 2003-11-25 Lion Corp Cosmetic impregnated sheet
DE10237281A1 (en) 2002-08-14 2004-03-04 Birken Gmbh Device for the continuous extraction of extract substances from plants
JP3779661B2 (en) 2002-09-13 2006-05-31 花王株式会社 Skin cosmetics
KR100489701B1 (en) * 2002-10-09 2005-05-16 주식회사 태평양 Submicron-liposome containing highly concentrated triterpenoid and method for preparing thereof
JP2005004911A (en) 2003-06-13 2005-01-06 Ikuta Insatsu Kk Magnetic card
DE10329955A1 (en) * 2003-07-03 2005-02-03 Merck Patent Gmbh Use of a hydroalcoholic extract from bauhinia for the preparation of a preparation

Also Published As

Publication number Publication date
HUS1600032I1 (en) 2016-08-29
NO20070390L (en) 2007-03-16
CA2571606C (en) 2011-07-19
KR20070046821A (en) 2007-05-03
WO2005123037A1 (en) 2005-12-29
PL1758555T3 (en) 2009-07-31
ZA200610304B (en) 2007-11-28
NO2016012I2 (en) 2016-07-07
ATE423546T1 (en) 2009-03-15
PT1758555E (en) 2009-04-24
DE502005006701D1 (en) 2009-04-09
CY2016025I1 (en) 2016-10-05
RS50832B (en) 2010-08-31
CA2571606A1 (en) 2005-12-29
US20140050790A1 (en) 2014-02-20
US8536380B2 (en) 2013-09-17
CN1972668A (en) 2007-05-30
AU2005253732A1 (en) 2005-12-29
NZ552280A (en) 2010-10-29
RS50832B2 (en) 2018-09-28
CY1109066T1 (en) 2014-07-02
RU2007102084A (en) 2008-07-27
SI1758555T1 (en) 2009-08-31
BRPI0512288A (en) 2008-03-25
DK1758555T3 (en) 2009-06-22
US20070299285A1 (en) 2007-12-27
LTC1758555I2 (en) 2017-11-10
LU93142I2 (en) 2016-09-06
UA88308C2 (en) 2009-10-12
NO336747B1 (en) 2015-10-26
EP1758555B2 (en) 2011-09-07
NL300823I2 (en) 2017-06-22
AU2005253732B2 (en) 2009-07-16
NO2016012I1 (en) 2016-07-07
PL1758555T5 (en) 2011-12-30
JP2008503530A (en) 2008-02-07
IL180057A0 (en) 2007-05-15
EP1758555A1 (en) 2007-03-07
AU2005253732C1 (en) 2010-01-21
CN1972668B (en) 2013-01-09
MXPA06015233A (en) 2007-12-12
ES2323082T3 (en) 2009-07-06
BRPI0512288B8 (en) 2021-05-25
DK1758555T4 (en) 2011-12-19
US8828444B2 (en) 2014-09-09
FR16C1003I1 (en) 2016-08-26
LU93142I9 (en) 2024-11-04
RU2430717C2 (en) 2011-10-10
SI1758555T2 (en) 2009-08-31
ES2323082T5 (en) 2012-01-05
JP4468987B2 (en) 2010-05-26
CY2016025I2 (en) 2016-10-05
FR16C1003I2 (en) 2018-01-19
DE102004030044A1 (en) 2006-01-12
BRPI0512288B1 (en) 2019-05-21
IL180057A (en) 2013-11-28
KR101162991B1 (en) 2012-07-10
EP1758555B1 (en) 2009-02-25

Similar Documents

Publication Publication Date Title
BE2022C549I2 (en)
BE2016C067I2 (en)
FR14C0074I1 (en)
IN2014MU01533A (en)
JP2004288168A5 (en)
BRPI0518216C1 (en)
JP2004233983A5 (en)
IN2006KO03744A (en)
JP2004225049A5 (en)
JP2004316654A5 (en)
FR16C1003I1 (en)
IN2007CH02034A (en)
ECSDI055830S (en)
JP2004215669A5 (en)
IN2014DN02209A (en)
IL162512A0 (en)
JP2005158034A5 (en)
JP2004320996A5 (en)
JP2005204924A5 (en)
JP2004237739A5 (en)
JP2005207818A5 (en)
FIU20040171U1 (en)
BRMU8403678U (en)
ECSDI045299S (en)
CN3375191S (en)